A direct oral anticoagulant reduces thrombus formation and prevents ischemic stroke in eligible people with atrial fibrillation. It is usually preferred to warfarin but is not appropriate for every valve or kidney-function situation.
The decision to anticoagulate should use the stroke-risk assessment in regional guidance and shared decision-making, not the presence or absence of symptoms alone. The dose of a direct oral anticoagulant, or DOAC, must follow drug-specific criteria for kidney function, age, weight, and interactions and must not be reduced without a valid basis. Bleeding is the major risk. A bleeding score helps correct modifiable factors and intensify review; it should not alone deny anticoagulation. Different DOAC ingredients and dosing frequencies are not interchangeable at the same dose. Safe treatment requires the correct drug and dose, on-time use, recognition of bleeding, periodic kidney review, and individualized interruption and restart plans for procedures, acute illness, or new interacting drugs. A missed dose can quickly reduce protection.
Quick Reference
Observation
0 mins
Department
Cardiology
Who Is This For
Step-by-Step Process

Assess stroke risk, modifiable bleeding factors, valve disease, and patient preferences according to regional guidance.
Choose the specific DOAC and dose from kidney function, age, weight, and interactions and check for a mechanical valve, moderate-to-severe mitral stenosis, or another exclusion.
Explain daily use and responses to a missed dose or bleeding, and agree in advance how to stop and restart around surgery, dental work, acute illness, or a new interacting medicine.
Recheck dose and anticoagulant choice as age, weight, kidney and liver function, bleeding, falls, and other medicines change.
Many people at high stroke risk need long-term anticoagulation. Temporary absence of atrial fibrillation or successful ablation does not automatically justify stopping it.
Cost Information
What's Included
Costs are quoted in Chinese yuan (RMB). For full self-payment without Chinese medical insurance, estimate cost only after the clinician specifies the DOAC generic name, dose, strength, manufacturer, and quantity for 30 days. Itemize the medicine separately from kidney and liver tests, blood count, and follow-up. Changes in kidney function, age, weight, or interacting medicines may require a dose or product change.
Before Your Visit
If you already have recent valid test results, bring the reports. If not, these assessments can usually be completed in China before the procedure.
Confirm electrocardiographic evidence of atrial fibrillation, stroke and bleeding risk, valve-disease type, and any other indication for anticoagulation.
Check blood count, kidney and liver function, weight, age, bleeding history, pregnancy possibility, and interactions with all prescribed and nonprescription products.
Specify the kidney-function method required by the particular product, such as Cockcroft–Gault, to avoid relying only on one laboratory report or reducing the dose without evidence.
Required to Bring
Electrocardiogram or monitor evidence, echocardiogram, and medical history relevant to stroke risk.
All medicines and supplements, recent blood count and kidney and liver results, earlier bleeding or falls, and planned surgical or dental procedures.
A medication card stating the DOAC generic name, dose, daily frequency, time of the last dose, and emergency contact information.
A companion is usually unnecessary but can help with communication, mobility, or remembering instructions when needed.
After Treatment
Take the medicine each day as prescribed. The response to a missed dose depends on the specific DOAC and timing; follow the product and clinician's instructions and do not double without advice.
Before any operation, dental procedure, new medicine, or herbal product, disclose anticoagulation. Interruption and restart timing must be individualized.
Black stools, vomiting blood, blood in urine, bleeding that will not stop, severe headache, or a fall with head impact requires immediate care and disclosure of anticoagulant use.
Review adherence and bleeding soon after initiation, then reassess according to age, kidney function, and clinical change. Uncontrolled bleeding, black stools, vomiting blood, head injury, or stroke symptoms requires immediate emergency care.
Related Conditions
Let Carevia help you find the right hospital, coordinate your treatment, and arrange every detail of your medical trip.
Need personalized guidance?
Our care coordinators can help you assess whether this procedure fits your situation.
Contact Us